Losartan/Hydrochlorothiazide
Brand name: Losartan-Hydrochlorothiazide
Rank #265 of 500 drugs by total cost
$46.3M
Total Cost
2,039,676
Total Claims
$46.3M
Total Cost
54,866
Prescribers
$23
Cost per Claim
414,538
Beneficiaries
5,316,181
30-Day Fills
$843
Avg Cost/Provider
37
Avg Claims/Provider
About Losartan/Hydrochlorothiazide
Losartan/Hydrochlorothiazide (sold as Losartan-Hydrochlorothiazide) was prescribed 2,039,676 times by 54,866 Medicare Part D providers in 2023, costing the program $46.3M. At $23 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 262 | Clozapine (Clozapine) | $47.0M | 491,951 |
| 263 | Pembrolizumab (Keytruda) | $46.9M | 3,947 |
| 264 | Glipizide (Glipizide) | $46.9M | 2,961,035 |
| 265 | Losartan/Hydrochlorothiazide (Losartan-Hydrochlorothiazide) | $46.3M | 2,039,676 |
| 266 | Darunavir (Prezista) | $46.0M | 21,793 |
| 267 | C1 Esterase Inhibitor (Haegarda) | $45.8M | 894 |
| 268 | Alectinib Hcl (Alecensa) | $45.7M | 2,686 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology